Literature DB >> 19528369

Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.

Elizabeth A Platz, Scott M Lippman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19528369     DOI： 10.1200/JCO.2009.22.2117

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Trace elements and vitamin E status in Nigerian patients with prostate cancer.

Authors:  O A Adaramoye; O Akinloye; I K Olatunji
Journal:  Afr Health Sci       Date:  2010-03       Impact factor: 0.927

2.  Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.

Authors:  Sreenivasulu Chintala; Károly Tóth; Shousong Cao; Farukh A Durrani; Mary M Vaughan; Randy L Jensen; Youcef M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  2010-01-12       Impact factor: 3.333

Review 3.  Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research.

Authors:  Ganna Chornokur; Nagi B Kumar
Journal:  Cancer Causes Control       Date:  2013-06-05       Impact factor: 2.506

Review 4.  Lycopene for the prevention of prostate cancer.

Authors:  Dragan Ilic; Kristian M Forbes; Craig Hassed
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 5.  Friend or foe? The current epidemiologic evidence on selenium and human cancer risk.

Authors:  Marco Vinceti; Catherine M Crespi; Carlotta Malagoli; Cinzia Del Giovane; Vittorio Krogh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2013       Impact factor: 3.781
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.